Kathryn Plante, MS

Kathryn (Kate) Plante, MS, is a Vice President who leads Fortrea’s global Market Access Consulting and HEOR group.

The Industry’s Core Constraint Is No Longer Technology — It’s Execution

Reducing ‘white space’: Pursuing achievable efficiencies in clinical trials

Choosing the right FSP model for your clinical challenge: a practical guide

Collaborative Delivery Advances a Rare Metabolic Disease Program for an APAC Biotech

Driving a Faster Respiratory Clinical Trial for a Biotech

Antibody Drug Conjugates (ADCs): A guide to Regulatory Clinical Development

The history, regulatory journey and Fortrea’s revival of Rifampin in DDI studies